What Your Blood Pressure Reading Doesn't Explain

Elevated blood pressure is among the most commonly treated findings in primary care, and antihypertensive medication is among the most widely prescribed drug class globally. It is also, in a significant proportion of cases, a sign pointing to something specific that medication suppresses but does not address.

Blood pressure is the product of cardiac output and peripheral vascular resistance. Elevated blood pressure means either the heart is pumping too hard, the blood vessels are too constricted, or both. The question “why?” — which factor, and what is driving it — is rarely systematically answered before medication is initiated. Antihypertensives reduce the number. They do not investigate the cause.

Insulin Resistance — The Most Common Unidentified Driver

Insulin resistance causes hypertension through several mechanisms: elevated insulin stimulates the sympathetic nervous system, directly increasing heart rate and cardiac output; insulin promotes renal sodium retention; insulin increases vascular smooth muscle proliferation and stiffness; and elevated insulin reduces endothelial nitric oxide production, impairing vasodilation.

The standard hypertension workup includes fasting glucose and sometimes HbA1c. It does not include fasting insulin or HOMA-IR. A patient with insulin resistance driving their hypertension — which is extremely common in overweight patients with hypertension and metabolic syndrome features — will have normal fasting glucose while insulin resistance is already significantly elevating vascular resistance. The glucose test misses this entirely. Fasting insulin does not.

Magnesium — The Vascular Mineral

Magnesium is required for vascular smooth muscle relaxation. It is a physiological calcium antagonist — it competes with calcium for entry into smooth muscle cells, preventing the sustained contraction that produces elevated vascular resistance. Magnesium deficiency therefore directly increases peripheral vascular resistance and blood pressure.

Magnesium deficiency is extremely common — estimated at 45–50% of the US and UK population. Serum magnesium is the last marker to fall in deficiency (the body maintains serum magnesium at the expense of tissue and intracellular stores), making it a poor detection tool. RBC magnesium is a more sensitive functional marker. Multiple meta-analyses demonstrate that magnesium supplementation reduces blood pressure by 3–5 mmHg — a clinically meaningful effect achievable without pharmaceutical side effects.

The Isometric Exercise Evidence

As covered in the Appliance of Science series, the 2023 British Journal of Sports Medicine meta-analysis of 270 RCTs found isometric exercise (wall sits, handgrip holds at 20–30% MVC, four 2-minute holds, three times weekly) produces the largest blood pressure reduction of any exercise type: 8.24 mmHg systolic. This exceeds the effect of most first-line antihypertensive drug classes in mild hypertension. It works via eNOS upregulation and chronic increases in endothelial nitric oxide production.

For a patient with mild hypertension (130–140 mmHg systolic), a structured isometric protocol alongside magnesium supplementation, insulin resistance assessment, and potassium intake optimisation represents a clinically meaningful non-pharmacological intervention that addresses the actual drivers rather than the reading. Under GP supervision, with regular monitoring, this is a legitimate functional approach to early-stage hypertension.

Blood pressure is a sign, not a diagnosis. The number tells you the output. It does not tell you which of the six or eight possible inputs is driving it. Treating the number without identifying the input is effective medicine by one measure and incomplete medicine by another.